Onkologie, Hämatologie - Daten und Informationen
SitemapSitemap  


Literatur zu Kapitel 3: Radiologische Diagnostik des multiplen Myeloms

Autor/en: Stefan Delorme, Andrea Baur-Melnyk
Letzte Änderung: 30.06.2011
  • Baur A.
    Diagnostik des Plasmozytoms mit der MRT.
    Radiologe 2000;40:716-722. PMID:11006942
    [Medline]


  • Baur A et al.
    Infiltrationsmuster des Plasmozytoms in der Magnetresonanztomographie.
    Fortschritte auf dem Gebiet der Röntgenstrahlen und der neuen Bildgebenden Verfahren 1996;164:457-463. PMID:8688501
    [Medline]


  • Baur A et al.
    Magnetic resonance imaging as a supplement for the clinical staging system of Durie and Salmon?
    Cancer 2002;95:1334-1345. PMID:12216103
    [Medline]


  • Baur A et al.
    Neovascularization of bone marrow in patients with diffuse multiple myeloma: a correlative study of magnetic resonance imaging and histopathologic findings.
    Cancer 2004;101:2599-2604. PMID:15503306
    [Medline]


  • Baur-Melnyk A, Reiser M.
    Staging des multiplen Myeloms mit der MRT: Vergleich zur MSCT und zur konventionellen Röntgendiagnostik.
    Radiologe 2004;44:874-881. PMID:15365631
    [Medline]


  • Baur-Melnyk A et al.
    Role of MRI for the diagnosis and prognosis of multiple myeloma.
    Eur J Radiol 2005;55:56-63. PMID:15950101
    [Medline]


  • Dankerl A et al.
    Multiple Myeloma: Molecular Imaging with 11C-Methionine PET/CT - Initial Experience.
    Radiology 2007;242:498-508. PMID: 17179397
    [Medline]


  • Durie BG.
    The role of anatomic and functional staging in myeloma: description of Durie/Salmon plus staging system.
    Eur J Cancer 2006;42:1539-1543. PMID:16777405
    [Medline]


  • Durie BG, Salmon SE.
    A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival.
    Cancer 1975;36:842-854. PMID:1182674
    [Medline]


  • Durie BG et al.
    Whole-body (18)F-FDG PET identifies high-risk myeloma.
    J Nucl Med 2002;43:1457-1463. PMID: 12411548
    [Medline]


  • Durie BG et al.
    Myeloma management guidlines: a consensus report from the Scientific Advisors of the International Myeloma Foundation.
    Hematol J 2003;4:379-398. PMID:14671610
    [Medline]


  • Hillengass JK et al.
    Lumbar bone marrow microcirculation measurements from dynamic contrast-enhanced MRI is a predictor of event-free survival in progressive multiple myeloma.
    Clin Cancer Res 2007;13:475-481. PMID:17255268
    [Medline]


  • Horger M et al.
    The benefit of using whole-body, low-dose, nonenhanced, multidetector computed tomography for follow-up and therapy response monitoring in patients with multiple myeloma.
    Cancer 2007;109:1617-1626. PMID:17330855
    [Medline]


  • Hur J et al.
    Efficacy of multidetector row computed tomography of the spine in patients with multiple myeloma: comparison with magnetic resonance imaging and fluorodeoxyglucose-positron emission tomography.
    J Comput Assist Tomogr 2007;31:342-347. PMID:17538276
    [Medline]


  • Lecouvet FE et al.
    Stage III multiple myeloma: clinical and prognostic value of spinal bone marrow MR imaging.
    Radiology 1998;209:653-660. PMID:9844655
    [Medline]


  • Moulopoulos LA et al.
    Prognostic significance of magnetic resonance imaging in patients with asymptomatic multiple myeloma.
    J Clin Oncol 1995;13:251-256. PMID:7799027
    [Medline]


  • Nosas-Garcia S.
    Dynamic contrast-enhanced MRI for assessing the disease activity of multiple myeloma: Comparison with histological and clinical markers.
    Dissertation, Universität Heidelberg, 2004.


  • Nosas-Garcia S et al.
    Dynamic contrast-enhanced MRI for assessing the disease activity of multple myeloma: A comparative study with histology and biochemical markers.
    J Magn Reson Imaging 2005;22:154-162. PMID:15971177
    [Medline]


  • Ooi GC et al.
    Radiologic manifestations of primary solitary extramedullary and multiple solitary plasmacytomas.
    Am J Roentgenol 2006;186:821-827. PMID:16498114
    [Medline]


  • Raya JG et al.
    Methods and applications of diffusion imaging of vertebral bone marrow.
    J Magn Reson Imaging 2006;24:1207-1220. PMID:17075841
    [Medline]


  • Van de Berg BC et al.
    Stage I multiple myeloma: Value of MR imaging of the bone marrow in the determination of prognosis.
    Radiology 1996;201:243-246. PMID:8816551
    [Medline]


  • Walker RB et al.
    Magnetic resonance imaging in multiple myeloma: diagnostic and clinical implications.
    J Clin Oncol 2007;25:1121-1128. PMID:17296972
    [Medline]


  • Wasser K et al.
    Dynamische MRT des Knochenmarks zum Monitoring des Multiplen Myeloms unter Thalidomid-Monotherapie oder Kombination mit CED-Chemotherapie.
    Fortschritte auf dem Gebiet der Röntgenstrahlen und der neuen Bildgebenden Verfahren 2004;176:1285-1295. PMID:15346264
    [Medline]


  • Wasser K et al.
    Korrelation zwischen MRT und Histopathologie des Knochenmarks bei Patienten mit Multiplem Myelom.
    Fortschritte auf dem Gebiet der Röntgenstrahlen und der neuen Bildgebenden Verfahren 2005;177:1116-1122. PMID:16021544
    [Medline]


  • Zamagni E et al.
    A prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in newly diagnosed multiple myeloma.
    Haematologica 2007;92:50-55. PMID:17229635
    [Medline]


  • Zechmann C et al.
    Where is the primary tumor?
    Lancet 2007;370:1800. PMID:18037083
    [Medline]


Bei ONKODIN publiziert in Kooperation mit "Deutscher Ärzte-Verlag"; Publikation als Buch: Deutscher Ärzte-Verlag  Deutscher Ärzte-Verlag [Mehr]
Aktuelle Berichte vom 58th
ASH Annual Meeting 2016,
San Diego, Kalifornien, USA [Mehr]
2016 ASCO Annual Meeting - aktuelle Berichte. Dieser Service wird gefördert durch:
mehr 
[Mehr]